Advisory Council for the Elimination of Tuberculosis (ACET), 65555 [2012-26490]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 209 / Monday, October 29, 2012 / Notices
533–6800, Toll Free 1 (800) CDC–INFO,
Email ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: October 22, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2012–26490 Filed 10–26–12; 8:45 am]
Dated: October 22, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
[FR Doc. 2012–26495 Filed 10–26–12; 8:45 am]
Food and Drug Administration
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
[Docket No. FDA–2012–N–0547]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis (ACET)
rmajette on DSK2TPTVN1PROD with
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates: 8:30 a.m.–5:30 p.m.,
December 4, 2012; 8:30 a.m.–2:30 p.m.,
December 5, 2012.
Place: CDC, Corporate Square, 1800
Corporate Boulevard, Building 8, 1st Floor
Conference Room, Atlanta, Georgia 30329,
Telephone: (404) 639–8317.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This council advises and makes
recommendations to the Secretary of Health
and Human Services, the Assistant Secretary
for Health, and the Director, CDC, regarding
the elimination of tuberculosis. Specifically,
the Council makes recommendations
regarding policies, strategies, objectives, and
priorities; addresses the development and
application of new technologies; and reviews
the extent to which progress has been made
toward eliminating tuberculosis.
Matters To Be Discussed: Agenda items
include the following topics: (1) CDC’s efforts
on global tuberculosis control; (2) The
epidemiology of TB–HIV in the United
States; (3) Post-deployment tuberculosis in
the United States military; (4) ACET
workgroups activities updates; and (5) other
tuberculosis-related issues.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Margie Scott-Cseh, CDC, 1600 Clifton Road
NE., M/S E–07, Atlanta, Georgia 30333,
Telephone: (404) 639–8317.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
VerDate Mar<15>2010
13:18 Oct 26, 2012
Jkt 229001
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Survey on the
Occurrence of Foodborne Illness Risk
Factors in Selected Retail and
Foodservice Facility Types (2013–
2022)
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995
(the PRA).
DATES: Fax written comments on the
collection of information by November
28, 2012.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–NEW and
title ‘‘Survey on the Occurrence of
Foodborne Illness Risk Factors in
Selected Retail and Foodservice Facility
Types (2013–2022).’’ Also include the
FDA docket number found in brackets
in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Ila
S. Mizrachi, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
7726, Ila.Mizrachi@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUMMARY:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
65555
Survey on the Occurrence of Foodborne
Illness Risk Factors in Selected Retail
and Foodservice Facility Types (2013–
2022)—(OMB Control Number 0910–
NEW)
I. Background
In 1998, the U.S. Food and Drug
Administration’s National Retail Food
Team initiated a 10-year voluntary
survey to measure trends in the
occurrence of foodborne illness risk
factors—preparation practices and
employee behaviors most commonly
reported to the Centers for Disease
Control and Prevention (CDC) as
contributing factors to foodborne illness
outbreaks at the retail level.
Specifically, the survey included data
collection inspections of various types
of retail and foodservice establishments
at 5-year intervals (1998, 2003, and
2008) in order to observe and document
trends in the occurrence of the
following foodborne illness risk factors:
• Food from Unsafe Sources.
• Poor Personal Hygiene.
• Inadequate Cooking.
• Improper Holding/Time and
Temperature.
• Contaminated Equipment/
Protection from Contamination.
FDA developed reports summarizing
the findings for each of the three data
collection periods (1998, 2003, and
2008) (Refs. 1 to 3). Data from all three
data collection periods were analyzed to
detect trends in improvement or
regression over time and to determine
whether progress had been made toward
the goal of reducing the occurrence of
foodborne illness risk factors in selected
retail and foodservice facility types (Ref.
4).
The research obtained from these
studies provides FDA a solid foundation
for developing a national retail food
program model that can be used by
Federal, State, local, and tribal agencies
to:
• Identify essential food safety
program performance measurements;
• Assess strengths and gaps in the
design, structure, and delivery of
program services;
• Establish program priorities and
intervention strategies focused on
reducing the occurrence of foodborne
illness risk factors; and
• Create a mechanism that justifies
program resources and allocates them to
program areas that will provide the most
significant public health benefits.
Using this 10-year survey as a
foundation, FDA is proposing to
conduct a new voluntary survey
encompassing annual data collections
over a 10-year period. The survey will
E:\FR\FM\29OCN1.SGM
29OCN1
]]>Agencies
[Federal Register Volume 77, Number 209 (Monday, October 29, 2012)]
[Notices]
[Page 65555]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-26490]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis (ACET)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Times and Dates: 8:30 a.m.-5:30 p.m., December 4, 2012; 8:30
a.m.-2:30 p.m., December 5, 2012.
Place: CDC, Corporate Square, 1800 Corporate Boulevard, Building
8, 1st Floor Conference Room, Atlanta, Georgia 30329, Telephone:
(404) 639-8317.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 100 people.
Purpose: This council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis. Specifically, the Council makes recommendations
regarding policies, strategies, objectives, and priorities;
addresses the development and application of new technologies; and
reviews the extent to which progress has been made toward
eliminating tuberculosis.
Matters To Be Discussed: Agenda items include the following
topics: (1) CDC's efforts on global tuberculosis control; (2) The
epidemiology of TB-HIV in the United States; (3) Post-deployment
tuberculosis in the United States military; (4) ACET workgroups
activities updates; and (5) other tuberculosis-related issues.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Margie Scott-Cseh, CDC,
1600 Clifton Road NE., M/S E-07, Atlanta, Georgia 30333, Telephone:
(404) 639-8317.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: October 22, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 2012-26490 Filed 10-26-12; 8:45 am]
BILLING CODE 4163-18-P
